{"id":26992,"date":"2024-05-13T14:26:31","date_gmt":"2024-05-13T12:26:31","guid":{"rendered":"https:\/\/www.krebs-praedisposition.de\/?post_type=lexikon&p=26992"},"modified":"2025-07-23T11:21:43","modified_gmt":"2025-07-23T09:21:43","slug":"neurofibromatosis-type-2","status":"publish","type":"lexikon","link":"https:\/\/www.krebs-praedisposition.de\/en\/lexikon\/neurofibromatosis-type-2\/","title":{"rendered":"NF2-associated Schwannomatosis"},"content":{"rendered":"

\"NF2-associated Schwannomatosis\" \u2013\u00a0What Is It?<\/h2><\/div>
<\/div><\/div><\/div><\/div>
<\/div><\/div><\/div>

NF2<\/em>-associated Schwannomatosis or central neurofibromatosis is a genetic, i.e., hereditary, disease that typically appears in young adulthood and is associated with the development of benign central nervous system tumors. A characteristic feature of patients with NF2<\/i>-associated Schwannomatosis is the development of benign tumors of the 8th cranial nerve, typically on both sides, so-called bilateral vestibular schwannomas, formerly called acoustic neuromas. As the 8th cranial nerve supplies hearing and balance, these tumors increase hearing loss and sometimes balance disorders or gait instability. Other benign tumors, brain tumors, and spinal tumors can also occur. A deterioration in vision, triggered by a particular form of lens opacity (juvenile cataract), is also characteristic. NF2<\/i>-associated Schwannomatosis is one of the tumor predisposition diseases.<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div>

Overview of the Chapters on This Page:<\/h4><\/div><\/div><\/div>